Last reviewed · How we verify
chlorhexidine 0.12%/Ethyl alcohol 7%
chlorhexidine 0.12%/Ethyl alcohol 7% is a disinfectant Small molecule drug developed by Hospital Regional de Alta Especialidad del Bajio. It is currently in Phase 3 development for Skin and soft tissue infections, Oral decontamination.
Chlorhexidine acts as a disinfectant by disrupting bacterial cell membranes, ultimately leading to cell death.
Chlorhexidine acts as a disinfectant by disrupting bacterial cell membranes, ultimately leading to cell death. Used for Skin and soft tissue infections, Oral decontamination.
At a glance
| Generic name | chlorhexidine 0.12%/Ethyl alcohol 7% |
|---|---|
| Sponsor | Hospital Regional de Alta Especialidad del Bajio |
| Drug class | disinfectant |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | Phase 3 |
Mechanism of action
Chlorhexidine's mechanism of action involves binding to the bacterial cell membrane, causing a loss of membrane integrity and ultimately leading to cell death. This results in the reduction of bacterial load and the prevention of infection.
Approved indications
- Skin and soft tissue infections
- Oral decontamination
Common side effects
- Skin irritation
- Allergic reactions
Key clinical trials
- Antiplaque Efficacy and Patient Reported Outcome of Chlorohexidine, Cetylpyridinium Chloride, and Essential Oil Mouthwashes in Orthodontic Patients (NA)
- Systemic Amoxicillin Plus Metronidazole in Peri-implantitis Treatment (PHASE4)
- Mouthwash With Chlorhexidine 0.12%/Ethyl Alcohol 7% Compared to Ethyl Alcohol 7% (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- chlorhexidine 0.12%/Ethyl alcohol 7% CI brief — competitive landscape report
- chlorhexidine 0.12%/Ethyl alcohol 7% updates RSS · CI watch RSS
- Hospital Regional de Alta Especialidad del Bajio portfolio CI
Frequently asked questions about chlorhexidine 0.12%/Ethyl alcohol 7%
What is chlorhexidine 0.12%/Ethyl alcohol 7%?
How does chlorhexidine 0.12%/Ethyl alcohol 7% work?
What is chlorhexidine 0.12%/Ethyl alcohol 7% used for?
Who makes chlorhexidine 0.12%/Ethyl alcohol 7%?
What drug class is chlorhexidine 0.12%/Ethyl alcohol 7% in?
What development phase is chlorhexidine 0.12%/Ethyl alcohol 7% in?
What are the side effects of chlorhexidine 0.12%/Ethyl alcohol 7%?
Related
- Drug class: All disinfectant drugs
- Manufacturer: Hospital Regional de Alta Especialidad del Bajio — full pipeline
- Therapeutic area: All drugs in Infectious Disease
- Indication: Drugs for Skin and soft tissue infections
- Indication: Drugs for Oral decontamination